Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,725.00
+115.00 (3.19%)
Apr 1, 2025, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 40.75 billion as of April 1, 2025.
Market Cap
40.75B
Enterprise Value
37.65B
Revenue
1.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,725.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 40.75B, a decrease of -54.84%. That is a compound annual growth rate of -67.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 40.75B | -8.20% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 38.03T |
| ALTEOGEN | 18.79T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,893.98B |
| HLB Co., Ltd. | 7,500.72B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,506.51B |